SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
Home ▸ Executive Leadership ▸ Dr. Subhendu Kumar Mohanty
Subhendu holds a PhD in Organic Chemistry from IIT Madras and completed postdoctoral research in Biophysical Sciences at the National Centre for Biological Sciences (NCBS), Bangalore.
Subhendu is a Syngene veteran with 18 years of experience, specializing in synthetic chemistry, medicinal chemistry, and drug discovery across multiple modalities, demonstrating strong leadership and collaborative skills.
Throughout his career, Subhendu has contributed significantly to advancing therapeutic development and scientific innovation.